186 related articles for article (PubMed ID: 24276457)
1. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract][Full Text] [Related]
2. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
3. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
4. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
7. Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.
Raval MV; Sturgeon C; Bentrem DJ; Elaraj DM; Stewart AK; Winchester DJ; Ko CY; Reynolds M
J Pediatr Surg; 2010 Oct; 45(10):1947-54. PubMed ID: 20920711
[TBL] [Abstract][Full Text] [Related]
8. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
9. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
[TBL] [Abstract][Full Text] [Related]
10. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
11. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
12. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
13. Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study.
Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
15. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma.
Machens A; Gimm O; Ukkat J; Sutter T; Dralle H
Langenbecks Arch Surg; 1999 Jun; 384(3):271-6. PubMed ID: 10437616
[TBL] [Abstract][Full Text] [Related]
16. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
18. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
20. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]